Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

University of Chicago Medical Center

University of Chicago Medical Center in Chicago, Illinois, United States is listed as a site for 555 registered clinical trials, 168 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 555
Ongoing 168

This page covers the site record University of Chicago Medical Center in Chicago, Illinois, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the University of Chicago Medical Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 555 trials counted.

  • Phase 1 68 trials
  • Phase 1/2 49 trials
  • Phase 2 137 trials
  • Phase 2/3 15 trials
  • Phase 3 117 trials
  • Phase 4 20 trials
  • Not applicable 82 trials
  • Observational 57 trials
  • Expanded access 10 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 171 trials
  • Completed 263 trials
  • Terminated 109 trials
  • Other 12 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 36

2000: 1 trials (Phase 3 1) 2001: 4 trials (Phase 3 1, Phase 1/2 1, Phase 1 2) 2002: 7 trials (Phase 3 3, Phase 2/3 1, Phase 2 1, Phase 1/2 2) 2003: 8 trials (Phase 4 1, Phase 2 7) 2004: 3 trials (Not applicable 1, Phase 3 1, Phase 1/2 1) 2005: 3 trials (Phase 3 1, Phase 2 1, Phase 1 1) 2006: 14 trials (Observational 1, Not applicable 1, Phase 4 3, Phase 3 2, Phase 2 6, Phase 1 1) 2007: 16 trials (Observational 2, Not applicable 1, Phase 3 7, Phase 2 4, Phase 1/2 1, Phase 1 1) 2008: 16 trials (Observational 2, Not applicable 1, Phase 4 2, Phase 3 3, Phase 2 5, Phase 1/2 2, Phase 1 1) 2009: 18 trials (Observational 3, Not applicable 1, Phase 4 2, Phase 3 7, Phase 2/3 1, Phase 2 4) 2010: 16 trials (Observational 3, Phase 4 1, Phase 3 3, Phase 2/3 2, Phase 2 6, Phase 1 1) 2011: 28 trials (Observational 5, Not applicable 3, Phase 3 5, Phase 2 11, Phase 1/2 2, Phase 1 2) 2012: 20 trials (Observational 4, Not applicable 5, Phase 4 1, Phase 3 1, Phase 2/3 1, Phase 2 5, Phase 1/2 2, Phase 1 1) 2013: 23 trials (Observational 2, Not applicable 5, Phase 4 2, Phase 3 6, Phase 2 4, Phase 1/2 2, Phase 1 2) 2014: 22 trials (Observational 3, Not applicable 5, Phase 4 3, Phase 3 2, Phase 2/3 1, Phase 2 3, Phase 1/2 1, Phase 1 4) 2015: 23 trials (Observational 3, Not applicable 4, Phase 3 4, Phase 2 7, Phase 1/2 2, Phase 1 3) 2016: 27 trials (Observational 3, Not applicable 4, Phase 4 2, Phase 3 4, Phase 2/3 1, Phase 2 6, Phase 1/2 3, Phase 1 4) 2017: 35 trials (Observational 4, Not applicable 6, Phase 4 1, Phase 3 6, Phase 2/3 2, Phase 2 10, Phase 1/2 2, Phase 1 4) 2018: 36 trials (Observational 3, Not applicable 6, Phase 3 7, Phase 2/3 1, Phase 2 9, Phase 1/2 3, Phase 1 7) 2019: 32 trials (Observational 1, Not applicable 5, Phase 3 8, Phase 2 5, Phase 1/2 5, Phase 1 8) 2020: 35 trials (Observational 3, Not applicable 10, Phase 3 7, Phase 2 5, Phase 1/2 5, Phase 1 5) 2021: 33 trials (Observational 2, Not applicable 2, Phase 4 1, Phase 3 6, Phase 2/3 1, Phase 2 10, Phase 1/2 6, Phase 1 5) 2022: 30 trials (Observational 3, Not applicable 4, Phase 4 1, Phase 3 8, Phase 2/3 2, Phase 2 5, Phase 1/2 4, Phase 1 3) 2023: 28 trials (Observational 2, Not applicable 3, Phase 3 6, Phase 2/3 1, Phase 2 8, Phase 1/2 2, Phase 1 6) 2024: 35 trials (Observational 8, Not applicable 7, Phase 3 3, Phase 2/3 1, Phase 2 9, Phase 1/2 2, Phase 1 5) 2025: 22 trials (Not applicable 6, Phase 3 12, Phase 2 2, Phase 1 2)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 10
2025 22
2024 35
2023 28
2022 30
2021 33
2020 35
2019 32
2018 36
2017 35

Showing 10 of 27 years.

Start your 14-day trial Email me all 27 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 555 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 192 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 293 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF